课题基金 / 基金详情

New and versatile chemical approaches for the synthesis of mRNA and tRNA

New and versatile chemical approaches for the synthesis of mRNA and tRNA
用于合成 mRNA 和 tRNA 的新型多功能化学方法
批准号:
BB/R008655/1
负责人:
Tom Brown
金额:
$92.19万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --

项目摘要

项目成果

Tom Brown的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The central dogma of molecular biology states that "DNA makes RNA makes proteins." We are interested in the possibility of intercepting the second step "RNA makes proteins." Two different RNA molecules, messenger RNA (mRNA) and transfer RNA (tRNA) are required in this step; they combine to convert the four letter code of DNA into the sequence of a protein. In principle this process could be manipulated by chemists who can assemble RNA by automated solid-phase methods. This would make it possible to produce chemically modified RNA and in turn modified proteins with new and improved properties by including unnatural building blocks (amino-acids). However, making the required long modified RNA strands to achieve this is beyond the scope of current chemical methods which are based on solid-phase synthesis. Therefore we will develop a new methodology, solid-phase synthesis of RNA combined with chemical ligation, to join together several chemically synthesised RNA strands in a chain to make mRNA molecules that are large enough to be used as therapeutic molecules and which can also be used to make useful proteins. Our synthetic mRNA (chemRNA) will have many advantages over biologically produced RNA. In particular it can be made on a very large scale, and it is possible to introduce many exotic chemical modifications that are not available to biological systems to enhance its stability and improve its ability to target particular organs in the body. This is an important objective because biochemically-derived, mRNA is starting to show promise in immunotherapy, infectious disease control and cancer therapy. Indeed, some mRNAs have even entered clinical trials. However, their development is limited by the difficulty in modifying them to make them stable in the human body. ChemRNA could also be used in combination with chem-tRNA to make proteins that cannot be made by current biochemical or biological methods. Chemical evolution in a test tube could then be used to produce new proteins with enhanced properties for use in many fields including biotechnology and synthetic biology.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.tet.2019.130914
发表时间: 2020-02-14
期刊: TETRAHEDRON
影响因子: 2.1
作者: [Baker, Ysobel R., Traore, Diallo, Brown, Tom]
通讯作者: Brown, Tom
DOI: 10.1093/nar/gkab720
发表时间: 2021-09-20
期刊: Nucleic acids research
影响因子: 14.9
作者: [Baker YR, Yuan L, Chen J, Belle R, Carlisle R, El-Sagheer AH, Brown T]
通讯作者: Brown T
DOI: 10.1021/jacs.1c08057
发表时间: 2021-10-06
期刊: Journal of the American Chemical Society
影响因子: 15
作者: [Epple S, Modi A, Baker YR, Wȩgrzyn E, Traoré D, Wanat P, Tyburn AES, Shivalingam A, Taemaitree L, El-Sagheer AH, Brown T]
通讯作者: Brown T
DOI: 10.1039/d2cb00100d
发表时间: 2022-06-08
期刊: RSC CHEMICAL BIOLOGY
影响因子: 4.1
作者: [Dysko, Anna, Baker, Ysobel R., McClorey, Graham, Wood, Matthew J. A., Fenner, Sabine, Williams, Glynn, El-Sagheer, Afaf, Brown, Tom]
通讯作者: Brown, Tom
Advancing Oligonucleotide Therapeutics
  • 批准号:
    BB/W003902/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $97.01万
  • 财政年份:
    2022
  • 负责人:
    Tom Brown
  • 依托单位:
CRISPR Chemistry
  • 批准号:
    EP/S019944/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $32.39万
  • 财政年份:
    2019
  • 负责人:
    Tom Brown
  • 依托单位:
New oligonucleotide analogues for therapeutic applications
  • 批准号:
    BB/S018794/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $59.02万
  • 财政年份:
    2019
  • 负责人:
    Tom Brown
  • 依托单位:
Creating artificial oligonucleotides by chemical synthesis - applications in life science research, crop protection and as novel therapeutics
  • 批准号:
    BB/R012474/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $1.22万
  • 财政年份:
    2017
  • 负责人:
    Tom Brown
  • 依托单位:
海外基金